-
Hospital Santo Amaro
Referência em obstetrícia, neonatologia e cirurgias em geral
-
IBIT
Matriz da FJS e destaque nacional no combate à tuberculose
-
Soluções em Saúde para Empresas
Referência em soluções completas e personalizadas em Segurança do Trabalho, Saúde Ocupacional e Gestão Ambiental.
-
Laboratório José Silveira
Qualidade e excelência em análises clínicas e anatomia patológica
-
IBR
Modelo em reabilitação de casos de limitações psicomotoras
-
Hospital Cristo Redentor
Atende a demanda de partos e de emergências em Itapetinga (BA)
-
Centro de Reabilitação da Ribeira
Atendimento especializado a pacientes com deficiências
-
Hospital Geral de Itaparica
Atendimento de urgência, obstétrico e cirúrgico
-
Santa Casa de Jequié
Qualidade em assistência obstétrica e clínica em Jequié (BA)
-
Saúde e Cidadania
Programa que leva saúde e assistência social a quem mais precisa
-
NICSA - Memorial em Santo Amaro
Memorial em Santo Amaro
Necrotic cell death during Mycobacterium tuberculosis (Mtb) infection is considered host detrimental since it facilitates mycobacterial spread. Ferroptosis is a type of regulated necrosis induced by accumulation of free iron and toxic lipid peroxides. We observed that Mtb-induced macrophage necrosis is associated with reduced levels of glutathione and glutathione peroxidase-4 (Gpx4), along with increased free iron, mitochondrial superoxide, and lipid peroxidation, all of which are important hallmarks of ferroptosis. Moreover, necrotic cell death in Mtb-infected macrophage cultures was suppressed by ferrostatin-1 (Fer-1), a well-characterized ferroptosis inhibitor, as well as by iron chelation. Additional experiments in vivo revealed that pulmonary necrosis in acutely infected mice is associated with reduced Gpx4 expression as well as increased lipid peroxidation and is likewise suppressed by Fer-1 treatment. Importantly, Fer-1–treated infected animals also exhibited marked reductions in bacterial load. Together, these findings implicate ferroptosis as a major mechanism of necrosis in Mtb infection and as a target for host-directed therapy of tuberculosis.
- Data de Publicação: 20/02/2019
- Autores: Eduardo P. Amaral, Diego L. Costa, Sivaranjani Namasivayam, Nicolas Riteau, Olena Kamenyeva, Lara Mittereder, Katrin D. Mayer-Barber,Bruno B. Andrade and Alan Sher